TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32719420

Group type: EXPERIMENTAL
Intervention: End-effector robot-assisted gait training (E-RAGT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Bodyweight-supported treadmill training (BWST)
Number of subjects: 28
Study: 35278336

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM) grafting
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (implant surgery alone)
Number of subjects: 20
Study: 35077296

Group type: EXPERIMENTAL
Intervention: RT-48h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RT-24h
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no RT)
Number of subjects: 10
Study: 35157537

Group type: EXPERIMENTAL
Intervention: CBCR programme 'Cogmed' with continuous support from a health professional
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: CBCR programme 'Brain+ Health' with continuous support from a health professional
Number of subjects: 72

Group type: COMPARATOR
Intervention: Active-control training with continuous support from a health professional
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: CBCR programme 'Brain+ Health' without support
Number of subjects: 72
Study: 34072293

Group type: EXPERIMENTAL
Intervention: Krill oil (2.3 g omega-3 daily)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Control (macadamia nut oil)
Number of subjects: 555
Study: 35243421

Group type: COMPARATOR
Intervention: Topically applied lactobacilli, daily application for 8 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 0
Study: 36176927

Group type: EXPERIMENTAL
Intervention: Combination of Chinese herbal fumigation sitz-bath and red ointment
Number of subjects: 118

Group type: COMPARATOR
Intervention: Red ointment therapy
Number of subjects: 118
Study: 32678132

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 3 months
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (CTL) group
Number of subjects: 55
Study: 35289545

Group type: EXPERIMENTAL
Intervention: Coaxial system with permanent infiltration anesthesia
Number of subjects: 296

Group type: COMPARATOR
Intervention: Conventional CT-guided transthoracic trepanobiopsy
Number of subjects: 296
Study: 34170932

Group type: EXPERIMENTAL
Intervention: HbA1c ADA definition (5.7%-6.4%)
Number of subjects: 1378

Group type: EXPERIMENTAL
Intervention: HbA1c WHO-IEC definition (6.0%-6.4%)
Number of subjects: 1378

Group type: EXPERIMENTAL
Intervention: FPG ADA definition (5.6-6.9 mmol/l)
Number of subjects: 1378

Group type: EXPERIMENTAL
Intervention: FPG ADA pre-diabetes criterion
Number of subjects: 1378
Study: 32481390

Group type: EXPERIMENTAL
Intervention: Laparoscopic intersphincteric resection
Number of subjects: 159

Group type: COMPARATOR
Intervention: Extralevator abdominoperineal resection (L-ELAPE)
Number of subjects: 159
Study: 35405973

Group type: EXPERIMENTAL
Intervention: 2800 IU of vitamin D3/day for 8 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 200
Study: 33932133

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 0
Study: 35850110

Group type: EXPERIMENTAL
Intervention: Endurance exercise (moderate- and vigorous-intensity levels)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Strength exercise (moderate- and vigorous-intensity levels)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-active control group
Number of subjects: 36
Study: 35710473

Group type: EXPERIMENTAL
Intervention: Erroneous example elaboration training
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 91
Study: 33246428

Group type: EXPERIMENTAL
Intervention: Capecitabine with bevacizumab and radiotherapy (arm A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Capecitabine and radiotherapy without bevacizumab (arm B)
Number of subjects: 0
Study: 36348422

Group type: EXPERIMENTAL
Intervention: mHealth-based exercise for 6 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual follow-up care for the first 3 months, then mHealth-based exercise for the next 3 months
Number of subjects: 80
Study: 33772702

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control (no workshop)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Self-Regulation (SR)
Number of subjects: 188
Study: 32548619

Group type: EXPERIMENTAL
Intervention: Sublobar resection (wedge resection or segmentectomy)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 430
Study: 35728369

Group type: EXPERIMENTAL
Intervention: Zuspan regimen of magnesium sulfate (MgSO4) for 24 hours
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Sibai regimen of magnesium sulfate (MgSO4) for 24 hours
Number of subjects: 33
Study: 33112259

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 1156

Group type: EXPERIMENTAL
Intervention: Turner syndrome (45,X)
Number of subjects: 1156

Group type: EXPERIMENTAL
Intervention: Turner syndrome women with a 45,X/46,XX karyotype
Number of subjects: 1156

Group type: EXPERIMENTAL
Intervention: Turner syndrome (general)
Number of subjects: 1156
Study: 35908008

Group type: EXPERIMENTAL
Intervention: Aerobic ergometer program for 2 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Seated flexibility exercise in addition to usual care
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aerobic ergometer program
Number of subjects: 15

Group type: COMPARATOR
Intervention: Seated flexibility exercise
Number of subjects: 15
Study: 34228836

Group type: EXPERIMENTAL
Intervention: Dipyrone 30 mg/kg q12h
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dipyrone 30 mg/kg q8h
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dipyrone 60 mg/kg q8h
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dipyrone 90 mg/kg q12h
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 32075695

Group type: EXPERIMENTAL
Intervention: Text messaging intervention (TMI) adjunct to standard care (30-min group-based smoking cessation counseling and nicotine patches)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care (30-min group-based smoking cessation counseling and nicotine patches)
Number of subjects: 80
Study: 36302567

Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg plus standard therapy
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study: 32014846

Group type: EXPERIMENTAL
Intervention: App-based intervention using Swedish Military training app (FMTK), Acupedo walking app, and LogMyFood food photography app.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Supervised exercise and health coaching intervention including 1 weekly supervised exercise session.
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: App-based intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Supervised exercise intervention
Number of subjects: 110
Study: 33032451

Group type: EXPERIMENTAL
Intervention: High rapport condition
Number of subjects: 114

Group type: COMPARATOR
Intervention: Low rapport condition
Number of subjects: 114
Study: 33248014

Group type: EXPERIMENTAL
Intervention: rONB
Number of subjects: 82

Group type: COMPARATOR
Intervention: sONB
Number of subjects: 82
Study: 35022952

Group type: EXPERIMENTAL
Intervention: Magnesium oxide (500 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Naproxen (500 mg)
Number of subjects: 64
Study: 33809392

Group type: EXPERIMENTAL
Intervention: Taekwondo training program (90 min, three times a week, for 12 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Taekwondo training program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 32039721

Group type: EXPERIMENTAL
Intervention: Group antenatal care
Number of subjects: 6

Group type: COMPARATOR
Intervention: Individual antenatal care
Number of subjects: 6
Study: 36047381

Group type: EXPERIMENTAL
Intervention: Empowering Community Pharmacists program (monthly resources/reminders + educational webinar)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (monthly reminders only)
Number of subjects: 55
Study: 33413291

Group type: EXPERIMENTAL
Intervention: IND/GLY/MF 150/50/80 μg (ICS medium-dose)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IND/GLY/MF 150/50/160 μg (ICS high-dose)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IND/GLY/MF (both doses)
Number of subjects: 33
Study: 32256907

Group type: EXPERIMENTAL
Intervention: 0.33% ropivacaine (Group QLB)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Saline (Group Con)
Number of subjects: 88
Study: 36408966

Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 60
Study: 35837868

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Radiomics signature
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Radiomics+Clinical nomogram
Number of subjects: 150
Study: 32938869

Group type: EXPERIMENTAL
Intervention: Professional mechanical plaque removal (PMPR) with removal of the superstructure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Professional mechanical plaque removal (PMPR) without removal of the superstructure
Number of subjects: 20
Study: 33857466

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 60

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 60
Study: 32106885

Group type: EXPERIMENTAL
Intervention: Intervention package consisting of structured sessions of behavior activation, problem-solving treatment, and parenting skills training delivered by primary maternal health care providers and supported by a 'neighborhood mother'.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (Control group).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention package.
Number of subjects: 0
Study: 32852138

Group type: EXPERIMENTAL
Intervention: LooH with a spiritual component (Spiritist passe Group - SPG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: LooH without a spiritual component (LooH Group - LHG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 120
Study: 32933470

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided great auricular nerve block (GANB) with 2 ml of 0.25% ropivacaine
Number of subjects: 60
Study: 34385093

Group type: EXPERIMENTAL
Intervention: Processed Aloe Vera Gel (PAG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32804414

Group type: EXPERIMENTAL
Intervention: Synthesized dynamic treatment regimes (DTRs)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Alternative methods
Number of subjects: 2
Study: 36001752

Group type: EXPERIMENTAL
Intervention: CNI (Calcineurin Inhibitors)
Number of subjects: 830

Group type: COMPARATOR
Intervention: Sirolimus
Number of subjects: 830
Study: 32102184

Group type: EXPERIMENTAL
Intervention: Dietary acid load (measured by PRAL score)
Number of subjects: 3081

Group type: EXPERIMENTAL
Intervention: Dietary acid load (measured by NEAP score)
Number of subjects: 3081

Group type: COMPARATOR
Intervention: HbA1c levels <5.6%
Number of subjects: 3081
Study: 36191758

Group type: EXPERIMENTAL
Intervention: Cordella PAP Sensor
Number of subjects: 0
Study: 33706698

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study: 32360128

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tablet
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 35905418

Group type: EXPERIMENTAL
Intervention: Conventional transarterial chemoembolization (cTACE)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: SMAART score
Number of subjects: 486

Group type: COMPARATOR
Intervention: ART score
Number of subjects: 486
Study: 34331112

Group type: COMPARATOR
Intervention: Without CAD
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: With CAD
Number of subjects: 200
Study: 32240761

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 2342

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 2342
Study: 34520295

Group type: EXPERIMENTAL
Intervention: Alcoholic beverage (target peak BrAC = .10%)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Nonalcoholic beverage
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Emotion regulation-focused intervention (cognitive restructuring or mindfulness) with alcohol (target peak BrAC = .08%)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group with alcohol (target peak BrAC = .08%)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Emotion regulation-focused intervention (cognitive restructuring or mindfulness) with nonalcoholic beverage
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group with nonalcoholic beverage
Number of subjects: 299
Study: 32077231

Group type: EXPERIMENTAL
Intervention: 0.9 mg ZGN-1061
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.8 mg ZGN-1061
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35227636

Group type: EXPERIMENTAL
Intervention: Text format of risk communication
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pictogram format of risk communication
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cube diagram format of risk communication
Number of subjects: 60
Study: 33413713

Group type: EXPERIMENTAL
Intervention: Yellow cassava (YC)
Number of subjects: 176

Group type: COMPARATOR
Intervention: White cassava (WC)
Number of subjects: 176
Study: 35874986

Group type: EXPERIMENTAL
Intervention: Team-based CPR plan
Number of subjects: 43
Study: 35596803

Group type: EXPERIMENTAL
Intervention: Melatonin 2 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33634687

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (MPFF) standard dose of 1000 mg once daily for 2 months (group 1)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (MPFF) double dose of 1000 mg twice daily for 1 month and then 1000 mg once daily for 1 month (group 2)
Number of subjects: 125
Study: 32110939

Group type: EXPERIMENTAL
Intervention: Gradual compression stockings (GCSs)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control condition (without GCSs)
Number of subjects: 16
Study: 36318686

Group type: EXPERIMENTAL
Intervention: Tap block in oblique subcostal approach (OSTAP)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Classic multimodal iv opioid analgesia
Number of subjects: 81

Group type: COMPARATOR
Intervention: Local anesthetic infiltration of the trocar insertion sites (LAI)
Number of subjects: 81
Study: 33735635

Group type: EXPERIMENTAL
Intervention: Rose oil softgel
Number of subjects: 70

Group type: COMPARATOR
Intervention: Omeprazole capsule
Number of subjects: 70
Study: 35783616

Group type: EXPERIMENTAL
Intervention: Ivermectin (0.4mg/kg per day for 3 days)
Number of subjects: 1158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1158
Study: 32178701

Group type: EXPERIMENTAL
Intervention: Astragalus injection
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Salvia Miltiorrhiza injection
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: All groups (including treatment and control)
Number of subjects: 160
Study: 34167901

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 150
Study: 32878737

Group type: EXPERIMENTAL
Intervention: Morning (fasting) exercise (MorEx)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Afternoon exercise (AftEx)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Evening exercise (EveEx)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Seated control
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Morning exercise (MorEx)
Number of subjects: 14
Study: 35125436

Group type: EXPERIMENTAL
Intervention: Microneedling and 5% 5-Fluorouracil (5-FU)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Microneedling and 0.5% 5-Fluorouracil (5-FU)
Number of subjects: 44

Group type: COMPARATOR
Intervention: 5% 5-Fluorouracil (5-FU) alone
Number of subjects: 44
Study: 34830950

Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionated RT/stereotactic body RT with focal RT dose escalation on intraprostatic tumor sides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate hypofractionated RT (MHRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 0
Study: 35432383

Group type: EXPERIMENTAL
Intervention: VACCIMEL plus BCG and GM-CSF
Number of subjects: 30

Group type: COMPARATOR
Intervention: IFNα2b
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: VACCIMEL
Number of subjects: 30
Study: 36289039

Group type: EXPERIMENTAL
Intervention: Physics Direct Patient Care (PDPC)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (standard radiation therapy workflow)
Number of subjects: 66
Study: 33527809

Group type: EXPERIMENTAL
Intervention: Azilsartan 40 mg
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Azilsartan 80 mg
Number of subjects: 303

Group type: COMPARATOR
Intervention: Telmisartan 40 mg
Number of subjects: 303
Study: 32232767

Group type: EXPERIMENTAL
Intervention: Dual-component molecular assay (mutation analysis and miR-146b-5p assay)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Combined use of mutation analysis and miR-146b-5p assay
Number of subjects: 156
Study: 35932889

Group type: EXPERIMENTAL
Intervention: Immediate telephone smoking cessation intervention (TSI) support with appropriate pharmacotherapy for 6 weeks
Number of subjects: 315

Group type: COMPARATOR
Intervention: Usual care (UC; very brief advice to quit and signposting to smoking cessation services)
Number of subjects: 315
Study: 33594133

Group type: EXPERIMENTAL
Intervention: tACS at 20 Hz (alpha)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tACS at 10 Hz (beta)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation (30 s of low-frequency transcranial random noise stimulation; tRNS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tACS at 10 Hz (alpha)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tACS at 20 Hz (beta)
Number of subjects: 0
Study: 32532781

Group type: EXPERIMENTAL
Intervention: Motor skill intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (standard practice)
Number of subjects: 300
Study: 34203476

Group type: EXPERIMENTAL
Intervention: Endotracheal Tube (ETT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 45
Study: 32544067

Group type: EXPERIMENTAL
Intervention: 18 mm group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 20 mm group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10 mm group
Number of subjects: 50
Study: 35000860

Group type: EXPERIMENTAL
Intervention: Presence of diabetic peripheral neuropathy
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Higher mean HDL/LDL cholesterol ratio
Number of subjects: 165
Study: 33774634

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study: 32381843

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SRP and doxycycline
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 51
Study: 35942626

Group type: EXPERIMENTAL
Intervention: Self-expanding valve (SEV)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Balloon-expandable valve (BEV)
Number of subjects: 416
Study: 34945036

Group type: EXPERIMENTAL
Intervention: Macintosh direct laryngoscope (MAC) without PPE
Number of subjects: 54
Study: 36305040

Group type: EXPERIMENTAL
Intervention: PrEP with coverage of 70%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no PrEP)
Number of subjects: 0
Study: 32888250

Group type: EXPERIMENTAL
Intervention: Internet-based weight-loss intervention
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard WIC
Number of subjects: 370
Study: 35039299

Group type: EXPERIMENTAL
Intervention: Zemedy app (CBT-based smartphone app)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Active control app (education and relaxation training)
Number of subjects: 300
Study: 32931635

Group type: EXPERIMENTAL
Intervention: Otsu thresholding
Number of subjects: 45

Group type: COMPARATOR
Intervention: 3.3 SD above BP mean intensity
Number of subjects: 45

Group type: COMPARATOR
Intervention: IIR above 1.61
Number of subjects: 45

Group type: COMPARATOR
Intervention: Texture analysis for voxels above the 70th percentile
Number of subjects: 45
Study: 35233724

Group type: EXPERIMENTAL
Intervention: Low energy meal replacement plan (≈ 810 kcal/day)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 90
Study: 33521132

Group type: EXPERIMENTAL
Intervention: L-carnitine therapy
Number of subjects: 1455
Study: 32830463

Group type: EXPERIMENTAL
Intervention: Oral Janus kinase 1 (JAK1) inhibitor abrocitinib (dose range 10-200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36242741

Group type: EXPERIMENTAL
Intervention: Vidofludimus calcium (45 mg for 14 days)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 33218118

Group type: EXPERIMENTAL
Intervention: Proposed piezoelectric tactile sensor for tissue stiffness detection
Number of subjects: 5

Group type: COMPARATOR
Intervention: Unoptimized sensor
Number of subjects: 5
Study: 36215714

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy screening
Number of subjects: 274952

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 274952
Study: 33823960

Group type: EXPERIMENTAL
Intervention: Food-related behavioral activation (F-BA) therapy with placebo supplements
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Multi-nutrient supplements (omega-3 fatty acids and a multi-vitamin)
Number of subjects: 933

Group type: COMPARATOR
Intervention: Placebo supplements
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: F-BA therapy with multi-nutrient supplements
Number of subjects: 933